Literature DB >> 12062473

Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.

Patricia M Hinkle1, A Eugene Pekary, Shayani Senanayaki, Albert Sattin.   

Abstract

A large family of TRH-like peptides in the limbic region of rat brain including pGlu-Glu-Pro-NH(2) (EEP), pGlu-Val-Pro-NH(2) (Val(2)-TRH), Leu(2)-TRH, Phe(2)-TRH and Tyr(2)-TRH has recently been discovered. TRH (pGlu-His-Pro-NH(2)) has antidepressant, neuroprotective, analeptic, anticonvulsant, antiamnesic and euphoric properties, and other TRH-like peptides such as EEP exert several of these effects. A new TRH receptor (TRHR2) has been reported which is highly expressed in regions of rat brain that regulate attention and learning, arousal, sleep and processing of sensory information. The TRHR1 predominates in limbic structures involved in regulation of mood and in pituitary. This study examined the possibility that some of the newly discovered TRH-like peptides bind with high affinity to TRHR2, and that this receptor acts as the transducer for some of the CNS effects of this new class of neuropeptides. EEP, Val(2)-TRH and Leu(2)-TRH were analeptics, like TRH, but Phe(2)-TRH and Tyr(2)-TRH were not. The affinity and efficacy of TRH-like peptides for TRHR1 and TRHR2 were measured in HEK293 cells stably expressing these receptors. The IC(50) values of TRH-like peptides for displacement of [3H]TRH from TRHR2 were TRH<<<(Leu(2)-, Phe(2)-TRH)<(Gln(2)-, Ser(2)-TRH)<<(Val(2)-, Tyr(2)-, Arg(2)-, Thr(2)-, and Glu(2)-TRH). The IC(50) for Leu(2)-TRH was about 100 times that for TRH. When tested at the calculated IC(50) values, TRH-like peptides stimulated calcium responses in cells expressing TRHR1 and TRHR2, indicating that the peptides act as weak agonists at both receptors. These results indicate that TRHR1 and TRHR2 do not mediate the behavioral effects of TRH-like peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062473     DOI: 10.1016/s0006-8993(02)02454-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  [Glu2]TRH dose-dependently attenuates TRH-evoked analeptic effect in mice.

Authors:  Vien Nguyen; Alevtina D Zharikova; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Brain Res Bull       Date:  2010-02-24       Impact factor: 4.077

2.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

3.  Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice.

Authors:  Chhuttan L Meena; Shubdha Ingole; Satyendra Rajpoot; Avinash Thakur; Prajwal P Nandeker; Abhay T Sangamwar; Shyam S Sharma; Rahul Jain
Journal:  RSC Adv       Date:  2015-06-23       Impact factor: 3.361

4.  Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.

Authors:  Richard J Naftalin; Philip Cunningham; Iram Afzal-Ahmed
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

5.  A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.

Authors:  Nicola Hogan; Kathy M O'Boyle; Patricia M Hinkle; Julie A Kelly
Journal:  Neurosci Lett       Date:  2007-11-17       Impact factor: 3.046

6.  Lipopolysaccharide modulation of thyrotropin-releasing hormone (TRH) and TRH-like peptide levels in rat brain and endocrine organs.

Authors:  Albert Eugene Pekary; Schetema A Stevens; Albert Sattin
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

7.  Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.

Authors:  Nanthakumar Thirunarayanan; Eshel A Nir; Bruce M Raaka; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2012-12-11       Impact factor: 7.853

8.  Design and exploratory neuropharmacological evaluation of novel thyrotropin-releasing hormone analogs and their brain-targeting bioprecursor prodrugs.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Szabolcs Szarka; Krisztina Konya; Laszlo Prokai
Journal:  Pharmaceutics       Date:  2013       Impact factor: 6.321

Review 9.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 10.  Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Molecules       Date:  2009-02-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.